HealthCare Global Enterprises Sets ₹512 Rights Issue Price: Record Date March 2, 2026

The board of HealthCare Global Enterprises Limited approved detailed terms for its proposed rights issue, fixing the issue price at ₹512 per share, following its earlier in-principle clearance on February 17 to raise up to ₹42,500.00 lakhs.

Rights Issue Terms and Structure

According to the company’s filing under Regulations 30 and 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the board authorised the offer of 82,94,566 fully paid-up equity shares of face value ₹10 each.

The aggregate issue size stands at ₹42,468.18 lakhs, assuming full subscription and payment of call monies. The rights equity shares carry a premium of ₹502 per share over face value, taking the total issue price to ₹512 per share.

The entitlement ratio has been fixed at 1:17 one right equity share for every 17 fully paid-up equity shares held as on the record date of March 2, 2026.

Rights Entitlements (REs) will be credited under ISIN INE075I20017 prior to issue opening. Eligible shareholders may either subscribe in full or renounce their entitlements, in whole or in part, through on-market or off-market transfers within the prescribed window.

The issue opens on March 11, 2026 and closes on March 25, 2026. The last date for on-market renunciation is March 20, 2026. Finalisation of basis of allotment and allotment itself are scheduled for March 27, 2026, with listing of the rights equity shares expected on April 1, 2026.

The board noted that it retains discretion to extend the issue period by up to 30 days from the opening date, subject to regulatory permissions. No withdrawal of applications will be permitted after the issue closing date.

Prior to the rights issue, the company had 141,007,637 equity shares outstanding. Post-issue equity capital is expected to increase to 149,302,203 shares, assuming full subscription.

The Letter of Offer has been approved for filing with the Securities and Exchange Board of India, BSE Limited and National Stock Exchange of India Limited. The board meeting commenced at 5.00 p.m. and concluded at 7.50 p.m.

Stock Market Snapshot

Share price of HealthCare Global Enterprises were trading at ₹561.20, down ₹14.45 or 2.51%, as of 1:40 p.m. IST on March 2, 2026, compared with the previous close of ₹575.65.

The stock opened at ₹563.00 and touched high of ₹564.95 and a low of ₹553.00 so far in the session. The company’s market capitalisation stood at approximately ₹7.91 crore, according to exchange data.

The 52-week high and low levels are ₹804.65 and ₹481.85, respectively.

Company Background

HealthCare Global Enterprises Limited operates a network of cancer care centres across India under the HCG brand. The company is listed on both BSE Limited and National Stock Exchange of India Limited.

Its equity shares carry a face value of ₹10 each and are traded under the symbol HCG.

Conclusion

The rights issue pricing at ₹512 per share represents a discount to the prevailing market price as of March 2, potentially shaping subscription response in the coming weeks. Completion remains subject to customary regulatory filings and adherence to the disclosed timetable.

Source:

• https://www.bseindia.com/xml-data/corpfiling/AttachHis/ebc6229d-4d3b-458e-89bf-ec992f6f1305.pdf
• https://www.nseindia.com/get-quote/equity/HCG/Healthcare-Global-Enterprises-Limited